Clinical trial Recruiting at 1 site Interventional Ages 6 to 18

Improving blood pressure control in children who faint

Official title: Impact of Postural Sway on Cardiovascular Control in Pediatric Patients With Syncope

Run by Simon Fraser University · NCT05633693 · Data updated 2026-11-12

This study is testing if certain movements can help children aged 6-18 who faint feel better by improving their blood pressure and heart function compared to regular advice.

Quick facts

Study typeInterventional
Ages6 Years to 18 Years
SexAll
Enrollment30 (estimated)
SponsorSimon Fraser University
Academic / other
Locations1 site (Burnaby, British Columbia)
StatusRecruiting
StartedApril 17, 2023
Main results expectedMay 2027
Study endsJune 2027
Registry record updatedApril 23, 2026
Trial IDNCT05633693 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are English-speaking pediatric patients aged 6-18 years with a diagnosis of recurrent fainting of vasovagal origin or associated with postural orthostatic tachycardia syndrome.

Probably not a fit

Patients with known cardiovascular diseases, structural heart issues, or other significant medical conditions may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This investigation aims to evaluate the effectiveness of specific counterpressure maneuvers, such as exaggerated sway and gluteal muscle clenching, in enhancing blood pressure and cardiovascular control in pediatric patients experiencing recurrent fainting episodes. The study will involve 35 participants aged 6-18 years, who will undergo a series of tests to measure cardiovascular responses to these maneuvers compared to standard recommendations. Data collected will include blood pressure, cerebral blood flow, and stroke volume, alongside participant demographics and medical history. The goal is to determine if these new maneuvers provide a significant improvement over traditional methods.

Why it matters

Potential benefit: If successful, this study could lead to more effective management strategies for children suffering from recurrent fainting episodes.

How similar studies have gone: While the approach of using counterpressure maneuvers is established, this specific investigation is novel in its focus on pediatric patients and the particular maneuvers being tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

We are looking for English speaking pediatric patients aged 6-18 years with a diagnosis of recurrent fainting (at least two episodes of fainting with loss of consciousness or near loss of consciousness in the last year) of a vasovagal origin or associated with the postural orthostatic tachycardia syndrome (POTS) (as determined by a paediatric cardiologist) to take part in this study.

Exclusion Criteria:

Those with a diagnosis of recurrent fainting accompanied by any of the following will not be eligible to take part:

Known history of:

* Suspected or confirmed cardiac arrhythmia (e.g., Wolff-Parkinson-White, Long QT)
* Traumatic head injury
* New presentation of a seizure disorder OR epilepsy recurrence
* Overdose or intoxication
* Structural heart disease
* Cardiovascular disease including hypertension, diabetes, or renal disease
* Hypoglycemia
* Physical and/or psychological disability that impact their ability to complete the tests

Female participants of childbearing age will be excluded if they are pregnant, or think they might be. Participants who are taking any cardiovascular acting medications, including treatment for cardiovascular disease, or medications for orthostatic syncope (e.g. fludrocortisone, slow-release sodium chloride, β-blockers, midodrine) will be excluded from the study.

In order to reduce the likelihood of transmission of COVID-19, participants will only be eligible to participate in the study if they have received full immunisation against COVID-19 according to current Health Canada guidelines. Accordingly, participants will be asked to provide evidence of their vaccination status in order to take part in the study.

Where it's running

  • Simon Fraser University
    Burnaby, British Columbia, Canada
    Recruiting

Study contacts

  • Principal investigator: Victoria E Claydon, PhD — Simon Fraser University
  • Study coordinator: Erin L Williams, BSc
  • Email: erin_williams_2@sfu.ca
  • Phone: 6048976372

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.